158 related articles for article (PubMed ID: 9660998)
1. Differences in the lipoprotein distribution of free and liposome-associated all-trans-retinoic acid in human, dog, and rat plasma are due to variations in lipoprotein lipid and protein content.
Wasan KM; Ramaswamy M; Ng SP; Wong W; Parrott SC; Ojwang JO; Wallace T; Cossum PA
Antimicrob Agents Chemother; 1998 Jul; 42(7):1646-53. PubMed ID: 9660998
[TBL] [Abstract][Full Text] [Related]
2. Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma.
Ramaswamy M; Wallace TL; Cossum PA; Wasan KM
Antimicrob Agents Chemother; 1999 Jun; 43(6):1424-8. PubMed ID: 10348764
[TBL] [Abstract][Full Text] [Related]
3. Preferential distribution of amphotericin B lipid complex into human HDL3 is a consequence of high density lipoprotein coat lipid content.
Kennedy AL; Wasan KM
J Pharm Sci; 1999 Nov; 88(11):1149-55. PubMed ID: 10564063
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins.
Cassidy SM; Strobel FW; Wasan KM
Antimicrob Agents Chemother; 1998 Aug; 42(8):1878-88. PubMed ID: 9687378
[TBL] [Abstract][Full Text] [Related]
5. Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin.
Wasan KM; Morton RE
Pharm Res; 1996 Mar; 13(3):462-8. PubMed ID: 8692743
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.
Ozpolat B; Lopez-Berestein G; Adamson P; Fu CJ; Williams AH
J Pharm Pharm Sci; 2003; 6(2):292-301. PubMed ID: 12935441
[TBL] [Abstract][Full Text] [Related]
7. Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia.
Swaminathan N; Lopez-Berestein G; Rudikoff S
Med Oncol; 1999 Jul; 16(2):119-28. PubMed ID: 10456660
[TBL] [Abstract][Full Text] [Related]
8. Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.
Wasan KM; Ramaswamy M; McIntosh MP; Porter CJ; Charman WN
J Pharm Sci; 1999 Feb; 88(2):185-90. PubMed ID: 9950636
[TBL] [Abstract][Full Text] [Related]
9. Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma.
Wasan KM; Ramaswamy M; Cassidy SM; Kazemi M; Strobel FW; Thies RL
Antimicrob Agents Chemother; 1997 Sep; 41(9):1871-5. PubMed ID: 9303376
[TBL] [Abstract][Full Text] [Related]
10. Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine.
Wasan KM; Pritchard PH; Ramaswamy M; Wong W; Donnachie EM; Brunner LJ
Pharm Res; 1997 Nov; 14(11):1613-20. PubMed ID: 9434283
[TBL] [Abstract][Full Text] [Related]
11. Modifications in high-density lipoprotein lipid composition and structure alter the plasma distribution of free and liposomal annamycin.
Wasan KM; Ng S; Cassidy SM
J Pharm Sci; 1997 Jul; 86(7):872-5. PubMed ID: 9232531
[TBL] [Abstract][Full Text] [Related]
12. The stereoselective distribution of halofantrine enantiomers within human, dog, and rat plasma lipoproteins.
Brocks DR; Ramaswamy M; MacInnes AI; Wasan KM
Pharm Res; 2000 Apr; 17(4):427-31. PubMed ID: 10870986
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A transfer between high- and low-density lipoproteins: independent from lipid transfer protein I-facilitated transfer of lipoprotein-coated phospholipids because of high affinity of cyclosporine a for the protein component of lipoproteins.
Kwong M; Sivak O; Kwong EH; Wasan KM
J Pharm Sci; 2001 Sep; 90(9):1308-17. PubMed ID: 11745783
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the pharmacokinetics of all-trans-retinoic acid (ATRA) in Wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell lines.
Su J; Zhang N; Ho PC
J Pharm Sci; 2008 Jul; 97(7):2844-53. PubMed ID: 17879972
[TBL] [Abstract][Full Text] [Related]
15. Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells.
Wasan EK; Waterhouse D; Sivak O; Bally MB; Klasa RJ; Wasan KM
Int J Pharm; 2002 Jul; 241(1):57-64. PubMed ID: 12086721
[TBL] [Abstract][Full Text] [Related]
16. Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form.
Parthasarathy R; Mehta K
Cancer Lett; 1998 Dec; 134(2):121-8. PubMed ID: 10025871
[TBL] [Abstract][Full Text] [Related]
17. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins.
Wasan KM; Brazeau GA; Keyhani A; Hayman AC; Lopez-Berestein G
Antimicrob Agents Chemother; 1993 Feb; 37(2):246-50. PubMed ID: 8452354
[TBL] [Abstract][Full Text] [Related]
18. Liposomes assembled from dimeric retinoic acid phospholipid with improved pharmacokinetic properties.
Lu L; Du Y; Ismail M; Ling L; Yao C; Fu Z; Li X
Eur J Pharm Sci; 2018 Jan; 112():186-194. PubMed ID: 29162478
[TBL] [Abstract][Full Text] [Related]
19. Blood and plasma lipoprotein distribution and gender differences in the plasma pharmacokinetics of lipid-associated annamycin.
Wasan KM; Kwong M
Pharmacol Toxicol; 1997 Jun; 80(6):301-7. PubMed ID: 9225368
[TBL] [Abstract][Full Text] [Related]
20. Association of the endotoxin antagonist E5564 with high-density lipoproteins in vitro: dependence on low-density and triglyceride-rich lipoprotein concentrations.
Wasan KM; Sivak O; Cote RA; MacInnes AI; Boulanger KD; Lynn M; Christ WJ; Hawkins LD; Rossignol DP
Antimicrob Agents Chemother; 2003 Sep; 47(9):2796-803. PubMed ID: 12936976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
